AI MARKET SCANNING

Trevi Therapeutics Inc

📅 Next Catalyst: Nov 12, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.25%
MAX GAP RECORD -10.34%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $TRVI
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+4.11%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
-3.55%
Mar 17, 2026 Earnings Release 2026-03-17 (AFTER CLOSE)
+5.99%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
+5.93%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-1.23%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+0.15%
Mar 18, 2025 Earnings Release 2025-03-18 (AFTER CLOSE)
+6.40%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.4%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $TRVI

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease, and refractory chronic cough….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗